Form 4 for FERG Ferguson Enterprises
Accepted 2025-10-15 00:00:00 ET · period of report 2025-10-13 · accession 0002030386-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-15 | 2025-10-13+ | FERG | Stirrup Allison | CHRO | A - Grant | $0.00 | +1,875 | 6,204 | +43% | $0 |
| DI | 2025-10-15 | 2025-10-14 | FERG | Stirrup Allison | CHRO | A - Grant | $0.00 | +76 | 137 | +125% | $0 |
| D | 2025-10-15 | 2025-10-13 | FERG | Stirrup Allison | CHRO | G - Gift | $0.00 | -70 | 4,988 | -1% | $0 |
| D | 2025-10-15 | 2025-10-13 | FERG | Stirrup Allison | CHRO | S - Sale+OE | $234.23 | -969 | 5,058 | -16% | -$227.0K |
| D | 2025-10-15 | 2025-10-13 | FERG | Stirrup Allison | CHRO | M - OptEx | $0.00 | +563 | 6,767 | +9% | $0 |
| D | 2025-10-15 | 2025-10-13 | FERG | Stirrup Allison | CHRO | F - Tax | $231.47 | -740 | 6,027 | -11% | -$171.3K |
| D | 2025-10-15 | 2025-10-13 | FERG | Stirrup Allison | CHRO | M - OptEx | $0.00 | -493 | 0 | -100% | $0 |
| D | 2025-10-15 | 2025-10-14 | FERG | Stirrup Allison | CHRO | A - Grant | $0.00 | +1,496 | 1,496 | New | $0 |
| DI | 2025-10-15 | 2025-10-13 | FERG | Stirrup Allison | CHRO | M - OptEx | $0.00 | -70 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-14 | A | A | 731 | $0.00 | 5,719 | D | — | — | (F7) The reported securities represent Restricted Stock Units granted under the Ferguson Enterprises Inc. 2023 Omnibus Equity Incentive Plan, which entitles the Reporting Person to receive the stated amount of Common Stock in three equal annual installments beginning on October 14, 2026 (the Vesting Dates), subject to the Reporting Person's continued service through the Vesting Dates or retirement, if eligible. |
| 2 | Common | Common Stock | 2025-10-14 | A | A | 76 | $0.00 | 137 | I | — | — | (F7) The reported securities represent Restricted Stock Units granted under the Ferguson Enterprises Inc. 2023 Omnibus Equity Incentive Plan, which entitles the Reporting Person to receive the stated amount of Common Stock in three equal annual installments beginning on October 14, 2026 (the Vesting Dates), subject to the Reporting Person's continued service through the Vesting Dates or retirement, if eligible. (F2) Includes 86 shares previously held in Indirect Holdings by Spouse that were transferred to a joint brokerage account now owned directly. |
| 3 | Common | Common Stock | 2025-10-13 | G | D | 70 | $0.00 | 4,988 | D | — | — | (F6) The reported transaction represents a bona-fide charitable gift to a Donor Advised Fund. |
| 4 | Common | Common Stock | 2025-10-13 | S | D | 969 | $234.23 | 5,058 | D | — | — | (F5) The reported price represents the volume-weighted average price (VWAP) of shares sold on the New York Stock Exchange . Sale prices for the reported transaction reported ranged between $234.200 and $234.275. Full information regarding the number of shares of Common Stock sold at each separate price in the range will be provided to the SEC, the Issuer or its shareholders upon request. |
| 5 | Common | Common Stock | 2025-10-13 | M | A | 563 | $0.00 | 6,767 | D | — | — | (F3) The Common Stock was received in settlement of a Conditional Share Award that vested on October 13, 2025. Includes 70 shares acquired by Spouse that are held in joint brokerage account. |
| 6 | Common | Common Stock | 2025-10-13 | A | A | 1,144 | $0.00 | 6,204 | D By spouse | — | — | (F1) The Common Stock was received in settlement of an October 13, 2022 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 10, 2025 by the Compensation Committee. Includes 142 shares acquired by Spouse that are held in joint brokerage account. (F2) Includes 86 shares previously held in Indirect Holdings by Spouse that were transferred to a joint brokerage account now owned directly. |
| 7 | Common | Common Stock | 2025-10-13 | F | D | 740 | $231.47 | 6,027 | D | — | — | (F4) Includes 65 shares from Spouse. |
| 8 | Derivative | Conditional Share Award | 2025-10-13 | M | D | 493 | $0.00 | 0 | D By spouse | — · — to — | 493 Common Stock | (F8) The Common Stock was received in settlement of a Conditional Share Award that vested on October 13, 2025. |
| 9 | Derivative | Stock Options (Right to Buy) | 2025-10-14 | A | A | 1,496 | $0.00 | 1,496 | D | $235.00 · — to 2035-10-14 | 1,496 Common Stock | (F9) The reported securities represent Stock Options granted under the Ferguson Enterprises Inc. 2023 Omnibus Equity Incentive Plan, which entitles the Reporting Person to receive the stated amount of Stock Options in three equal annual installments beginning on October 14, 2026, (the "Vesting Dates"), subject to the Reporting Person's continued service through the Vesting Dates or retirement, if eligible. |
| 10 | Derivative | Conditional Share Award | 2025-10-13 | M | D | 70 | $0.00 | 0 | I | — · — to — | 70 Common Stock | (F8) The Common Stock was received in settlement of a Conditional Share Award that vested on October 13, 2025. |